NEW YORK and SAN DIEGO, Oct. 14,
2021 /PRNewswire/ -- Cue Health Inc. (Nasdaq:
HLTH), a mission-driven healthcare technology company, and the
National Basketball Association (NBA) today announced that Cue will
serve as the league's Official Home and Point of Care Test for the
2021-22 season. The Cue COVID-19 Test for Home and Over The Counter
(OTC) Use is the first FDA-authorized molecular diagnostic test for
at-home and over-the-counter use without physician supervision or a
prescription.
Expanding on a relationship that began during the 2020 NBA
Restart in Orlando, Cue will
provide all 30 NBA teams and the league's referees with the
integrated Cue platform, which features both the portable Cue
Health Monitoring System and easy-to-use Cue COVID-19 tests for use
during the 2021-22 NBA season.
Cue's platform is a molecular diagnostic system that delivers
results directly to mobile smart devices – both Android and
iOS – in about 20 minutes. The Cue Health Enterprise
Dashboard allows for test results to be shared among players,
teams, doctors, and the league through a secure, web-based
application.
"The NBA has been at the forefront of health and safety from the
beginning of the COVID-19 pandemic and we are proud to expand our
relationship to become the league's Official Home and Point of Care
Test," said Ayub Khattak, co-founder
and CEO of Cue. "Since the NBA returned to the court last year, we
have worked closely with them to make our fast and accurate testing
available anywhere, anytime to prioritize players' health while
enabling more effective decision-making throughout the league.
For the coming season, we're honored to have the privilege of
helping keep players, coaches, staff, referees, and their families
healthy."
"After exploring a number of different at-home and point of care
COVID-19 testing options for the upcoming season, we selected Cue
thanks to its combination of accuracy, information management, ease
of use, and speed," said David
Weiss, NBA Senior Vice President, Player Matters. "The
health and safety of our players, coaches, staff and referees
continue to be at the forefront of all of our decision-making, and
we're thrilled to be able to employ the Cue platform as a part of
our Health & Safety Protocols for the 2021-22
season."
After collaborating during the 2020 NBA Restart in Orlando, the NBA began distributing the Cue
Health Monitoring System and Cue COVID-19 tests to support regular
testing of members of the NBA community at home and while
traveling during the latter part of the 2020-21 season,
following Cue Health's receipt of FDA Emergency Use Authorization
(EUA) for Home and Over The Counter Use. Results of this
home-testing program are expected to be published in a scientific
journal later this year. Cue previously received EUA from the
FDA in June of 2020 for its Cue COVID-19 Test for use in clinical
and point of care settings.
About Cue Health
Cue Health (Nasdaq: HLTH) is a
mission-driven healthcare technology company that puts consumers in
control of their health information and places diagnostic
information at the center of care. Cue Health enables people to
manage their health through real-time, actionable, and connected
health information, offering individuals and their healthcare
providers easy access to lab-quality diagnostics anywhere, anytime,
in a device that fits in the palm of the hand. Cue Health's
first-of-its-kind COVID-19 test was the first FDA-authorized
molecular diagnostic test for at-home and over-the-counter use
without physician supervision. Outside the United States, Cue Health has received the
CE mark in the European Union, Interim Order authorization from
Health Canada, and regulatory approval from India's Central Drugs Standard Control
Organisation. Cue was founded in 2010 and is headquartered in
San Diego. For more information,
please visit www.cuehealth.com.
About the NBA
The NBA is a global sports and media
business built around four professional sports leagues: the
National Basketball Association, the Women's National Basketball
Association, the NBA G League and the NBA 2K League. The NBA and the International
Basketball Federation (FIBA) also jointly operate the Basketball
Africa League (BAL). The NBA has established a major
international presence with games and programming available in 215
countries and territories in more than 50 languages, and
merchandise for sale in more than 100,000 stores in 100 countries
on six continents. NBA rosters at the start of the 2020-21
season featured 107 international players from 41 countries.
NBA Digital's assets include NBA TV, NBA.com, the NBA App and NBA
League Pass. The NBA has created one of the largest social
media communities in the world, with 1.9 billion likes and
followers globally across all league, team, and player
platforms. Through NBA Cares, the league addresses important
social issues by working with internationally recognized
youth-serving organizations that support education, youth and
family development, and health-related causes.
Forward-Looking Statements
Statements in this press release about future expectations, plans
and prospects, as well as any other statements regarding matters
that are not historical facts, may constitute "forward-looking
statements". These statements include, but are not limited to,
statements relating to the expected future publication of results
from Cue's 2020-21 home-testing program with the NBA. The words,
without limitation, "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "plan," "potential,"
"predict," "project," "should," "target," "will," "would" and
similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain
these or similar identifying words. Actual results may differ
materially from those indicated by such forward-looking statements
as a result of various important factors, including the factors
discussed in the "Risk Factors" section of the prospectus dated
September 23, 2021 filed by Cue with
the SEC. Any forward-looking statements contained in this press
release are based on the current expectations of Cue's management
team and speak only as of the date hereof, and Cue specifically
disclaims any obligation to update any forward-looking statement,
whether as a result of new information, future events
or otherwise.
These products have not been FDA cleared or approved;
but have been authorized by FDA under an
EUA. These products have been authorized only for the
detection of nucleic acid from SARS-CoV-2, not for any other
viruses or pathogens. The emergency use of these products
is only authorized for the duration of the declaration that
circumstances exist justifying the authorization of emergency use
of in vitro diagnostics for detection and/or diagnosis of COVID-19
under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act,
21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or
authorization is revoked sooner.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cue-health-to-provide-covid-19-testing-for-2021-22-nba-season-301400121.html
SOURCE Cue Health Inc.